Clinical trial
Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in…
NCT00075491 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00075491 |
|---|---|
| Title | Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme |
| Official title | A Phase II Evaluation With Correlative Studies Of Fenretinide (NSC 374551-4HPR) As A Single Agent In The Treatment Of Adult Patients With Recurrent Glioblastoma Multiforme |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor |
| Intervention type | Drug, Other, Procedure |
| Interventions | fenretinide, therapeutic conventional surgery, pharmacological study, laboratory biomarker analysis |
| Enrollment | 42 |
| Start date | Dec 1, 2003 |
| Primary completion | Mar 1, 2005 |
| First posted | Jan 12, 2004 |
| Last update posted | Jan 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: